Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06411158 · ClinicalTrials.gov registry record · NA
Training for Urinary Leakage Improvement After Pregnancy
A NA study of Urinary Incontinence and Delivery Complication, sponsored by NICHD Pelvic Floor Disorders Network.
- Recruiting
- Registry status
- NA
- Development phase
- 216
- Enrollment target
- 7
- Study locations
NCT06411158 is a NA study of Urinary Incontinence and Delivery Complication that is actively recruiting participants, run by NICHD Pelvic Floor Disorders Network. The registered enrollment target is 216 participants, below the 258-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (16% lower). The trial reports 7 study locations across 6 states.
The verdict
NCT06411158, a NA study of Urinary Incontinence and Delivery Complication, is actively recruiting participants, sponsored by NICHD Pelvic Floor Disorders Network.
- RECRUITING
- Registry status
- NA
- Development phase
- 216 participants
- Enrollment target
- 7
- Study locations
Study Summary
This is a multi-center, randomized single-blind nonsurgical trial conducted in approximately 216 primiparous postpartum women at high risk for prolonged/sustained pelvic floor disorders with symptomatic, bothersome urinary incontinence (UI) amenable to nonsurgical treatment. TULIP is a 3-Arm trial with two active interventions (Arms 1 and 2) and a Patient Education control arm (Arm 3). Arm 1 consists of pelvic floor muscle training (PFMT). Arm 2 uses a home biofeedback device (leva®). The primary outcome will be assessed at 6 months postpartum by blinded outcomes assessors, and follow-up will continue until 12 months postpartum.
Conditions Studied
Interventions
- OTHER Education
- OTHER Interventionist-guided training
- DEVICE Home pelvic floor exercises guided by the leva® device
Study Locations (7)
California
- Kaiser Permanente -- San Diego - San Diego
- University of California - San Diego - San Diego
Illinois
- University of Chicago - Chicago
North Carolina
- Duke University, Duke Division of Urogynecology and Reconstructive Pelvic Surgery - Durham
Pennsylvania
- University of Pennsylvania - Philadelphia
Rhode Island
- Brown/ Women and Infants Hospital of Rhode Island, Center for Women's Pelvic Medicine and Reconstructive Surgery - Providence
Texas
- University of Texas Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2024-11-12 |
| Est. Completion | 2027-11-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06411158
The ClinicalTrials.gov registry entry for NCT06411158 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 216 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 258-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (16% lower). The listed sponsor is NICHD Pelvic Floor Disorders Network, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Urinary Incontinence appearing as the primary indexed condition, and to 3 interventions - of which Education is the first listed.
NCT06411158 reports 7 study locations spanning 6 distinct geographic areas - top geographies include California, Illinois, North Carolina.
Frequently Asked Questions
What is clinical trial NCT06411158 about?
NCT06411158 is a clinical study titled "Training for Urinary Leakage Improvement After Pregnancy". This is a multi-center, randomized single-blind nonsurgical trial conducted in approximately 216 primiparous postpartum women at high risk for prolonged/sustained pelvic floor disorders with symptomatic, bothersome urinary incontinence (UI) amenable to nonsurgical treatment. TULIP is a 3-Arm trial ...
What is the current status of trial NCT06411158?
This trial is currently recruiting. It is a NA study. The enrollment target is 216 participants. The study started on 2024-11-12. Estimated completion is 2027-11-12.
What conditions does trial NCT06411158 study?
This clinical trial studies the following conditions: Urinary Incontinence, Delivery Complication.
What interventions are being tested in trial NCT06411158?
The interventions under investigation include: Education (OTHER), Interventionist-guided training (OTHER), Home pelvic floor exercises guided by the leva® device (DEVICE).
Who is sponsoring clinical trial NCT06411158?
This trial is sponsored by NICHD Pelvic Floor Disorders Network, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06411158 being conducted?
This trial has 7 study locations across California, Illinois, North Carolina, Pennsylvania, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
-
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
RECRUITING · NA
-
Improving Overactive Bladder Treatment Access and Adherence
RECRUITING · NA
-
Home Biofeedback Therapy for Dyssynergic Defecation, Fecal Incontinence and Urinary Incontinence
RECRUITING · NA
-
BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.